DataMeds AI (MEDS) Receivables - Net (2024 - 2026)

DataMeds AI (MEDS) has reported Receivables - Net for 3 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net fell 49.73% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (down 49.73% YoY), and the FY2025 full-year result was $2.0 million, down 45.86% from the prior year.
• Receivables - Net slipped to $1.9 million in Q1 2026 per MEDS's latest filing, from $2.0 million in the prior quarter.
• Across five years, Receivables - Net topped out at $3.8 million in Q1 2025 and bottomed at $1.9 million in Q1 2026.
• Historically, Receivables - Net has averaged $2.8 million across 3 years, with a median of $2.8 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Receivables - Net sank 45.86% in 2025, then plunged 49.73% in 2026.
• Over 3 years, Receivables - Net stood at $3.7 million in 2024, then tumbled by 45.86% to $2.0 million in 2025, then retreated by 2.58% to $1.9 million in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $1.9 million, $2.0 million, and $2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.